Ezetimibe 10 MG / simvastatin 40 MG Oral Tablet — RxCUI 476350
RxNorm drug concept · Semantic clinical drug
RxCUI 476350
Semantic clinical drug · SCD
● Current RxNorm concept 34 FDA products
79 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI476350
Official nameEzetimibe 10 MG / simvastatin 40 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped34
Package NDCs mapped79
Reported Medicaid activity (SDUD)3,300 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ezetimibe: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question — they actually work in completely different places. Statins lower cholesterol by slowing down how much your liver makes. Ezetimibe works in your gut, blocking a pro...
- What exactly does ezetimibe do, and how is it different from a statin?
- You can take it either way — with or without food. A big, fatty meal might slightly raise the peak level of the drug in your blood, but it doesn't change how much gets absorbed ove...
- Can I take ezetimibe with food, or does it need to be taken on an empty stomach?
🕸️ Concept Web — How Ezetimibe 10 MG / simvastatin 40 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ezetimibe 10 MG / simvastatin 40 MG Oral Tablet
RxCUI 476350 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Ezetimibe
341248IN -
Simvastatin
36567IN -
Ezetimibe / simvastatin
484211MIN
-
Ezetimibe
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vytorin
495215BN
-
Vytorin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ezetimibe / simvastatin Oral Tablet
476348SCDF -
Ezetimibe / simvastatin Oral Product
1163791SCDG -
Ezetimibe / simvastatin Pill
1163792SCDG -
Ezetimibe / simvastatin Oral Tablet [Vytorin]
1245438SBDF -
Vytorin Oral Product
1245439SBDG -
Vytorin Pill
1245440SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Ezetimibe / simvastatin Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ezetimibe 10 MG
350671SCDC -
Simvastatin 40 MG
316674SCDC -
Ezetimibe 10 MG / simvastatin 40 MG Oral Tablet [Vytorin]
1245441SBD -
Ezetimibe 10 MG / simvastatin 40 MG [Vytorin]
1245437SBDC
-
Ezetimibe 10 MG
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ezetimibe 10 MG
SCDC · 350671 -
Simvastatin 40 MG
SCDC · 316674 -
Ezetimibe / simvastatin Oral Tablet
SCDF · 476348 -
Ezetimibe / simvastatin Oral Product
SCDG · 1163791 -
Ezetimibe / simvastatin Pill
SCDG · 1163792
Brand-Name Concepts
-
Ezetimibe 10 MG / simvastatin 40 MG Oral Tablet [Vytorin]
SBD · 1245441 -
Ezetimibe 10 MG / simvastatin 40 MG [Vytorin]
SBDC · 1245437 -
Ezetimibe / simvastatin Oral Tablet [Vytorin]
SBDF · 1245438 -
Vytorin Oral Product
SBDG · 1245439 -
Vytorin Pill
SBDG · 1245440 -
Vytorin
BN · 495215
📦 FDA Products & Package NDCs
34 products · 79 package NDCs
79 package NDCs map to RxCUI 476350 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 16714-0778-01 | 30 TABLET in 1 BOTTLE (16714-778-01) | ezetimibe and simvastatin | NORTHSTAR RX LLC | 2019-08-19 |
| 16714-0778-02 | 90 TABLET in 1 BOTTLE (16714-778-02) | ezetimibe and simvastatin | NORTHSTAR RX LLC | 2019-08-19 |
| 16714-0779-01 | 30 TABLET in 1 BOTTLE (16714-779-01) | ezetimibe and simvastatin | NORTHSTAR RX LLC | 2019-08-19 |
| 16714-0779-02 | 90 TABLET in 1 BOTTLE (16714-779-02) | ezetimibe and simvastatin | NORTHSTAR RX LLC | 2019-08-19 |
| 16714-0780-01 | 30 TABLET in 1 BOTTLE (16714-780-01) | ezetimibe and simvastatin | NORTHSTAR RX LLC | 2019-08-19 |
| 16714-0780-02 | 90 TABLET in 1 BOTTLE (16714-780-02) | ezetimibe and simvastatin | NORTHSTAR RX LLC | 2019-08-19 |
| 16714-0781-01 | 30 TABLET in 1 BOTTLE (16714-781-01) | ezetimibe and simvastatin | NORTHSTAR RX LLC | 2019-08-19 |
| 16714-0781-02 | 90 TABLET in 1 BOTTLE (16714-781-02) | ezetimibe and simvastatin | NORTHSTAR RX LLC | 2019-08-19 |
| 43598-0742-10 | 1000 TABLET in 1 BOTTLE (43598-742-10) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 43598-0742-30 | 30 TABLET in 1 BOTTLE (43598-742-30) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 43598-0742-90 | 90 TABLET in 1 BOTTLE (43598-742-90) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 43598-0743-30 | 30 TABLET in 1 BOTTLE (43598-743-30) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 43598-0743-90 | 90 TABLET in 1 BOTTLE (43598-743-90) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 43598-0744-10 | 1000 TABLET in 1 BOTTLE (43598-744-10) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 43598-0744-30 | 30 TABLET in 1 BOTTLE (43598-744-30) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 43598-0744-90 | 90 TABLET in 1 BOTTLE (43598-744-90) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 43598-0745-05 | 500 TABLET in 1 BOTTLE (43598-745-05) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 43598-0745-30 | 30 TABLET in 1 BOTTLE (43598-745-30) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 43598-0745-90 | 90 TABLET in 1 BOTTLE (43598-745-90) | Ezetimibe and Simvastatin | Dr.Reddys Laboratories Inc | 2018-11-20 |
| 50090-4772-00 | 90 TABLET in 1 BOTTLE (50090-4772-0) | Ezetimibe and Simvastatin | A-S Medication Solutions | 2019-12-02 |
| 50090-7047-00 | 90 TABLET in 1 BOTTLE (50090-7047-0) | ezetimibe and simvastatin | A-S Medication Solutions | 2024-01-15 |
| 51407-0190-10 | 1000 TABLET in 1 BOTTLE (51407-190-10) | Ezetimibe and Simvastatin | Golden State Medical Supply, Inc. | 2019-04-29 |
| 51407-0191-10 | 1000 TABLET in 1 BOTTLE (51407-191-10) | Ezetimibe and Simvastatin | Golden State Medical Supply, Inc. | 2019-04-29 |
| 51407-0191-90 | 90 TABLET in 1 BOTTLE (51407-191-90) | Ezetimibe and Simvastatin | Golden State Medical Supply, Inc. | 2019-04-29 |
| 51407-0192-30 | 30 TABLET in 1 BOTTLE (51407-192-30) | Ezetimibe and Simvastatin | Golden State Medical Supply, Inc. | 2019-04-29 |
| 51407-0193-05 | 500 TABLET in 1 BOTTLE (51407-193-05) | Ezetimibe and Simvastatin | Golden State Medical Supply, Inc. | 2019-04-29 |
| 51407-0193-90 | 90 TABLET in 1 BOTTLE (51407-193-90) | Ezetimibe and Simvastatin | Golden State Medical Supply, Inc. | 2019-04-29 |
| 59651-0835-30 | 30 TABLET in 1 BOTTLE (59651-835-30) | Ezetimibe and Simvastatin | Aurobindo Pharma Limited | 2024-03-01 |
| 59651-0835-90 | 90 TABLET in 1 BOTTLE (59651-835-90) | Ezetimibe and Simvastatin | Aurobindo Pharma Limited | 2024-03-01 |
| 59651-0836-30 | 30 TABLET in 1 BOTTLE (59651-836-30) | Ezetimibe and Simvastatin | Aurobindo Pharma Limited | 2024-03-01 |
| 59651-0836-90 | 90 TABLET in 1 BOTTLE (59651-836-90) | Ezetimibe and Simvastatin | Aurobindo Pharma Limited | 2024-03-01 |
| 59651-0837-30 | 30 TABLET in 1 BOTTLE (59651-837-30) | Ezetimibe and Simvastatin | Aurobindo Pharma Limited | 2024-03-01 |
| 59651-0837-90 | 90 TABLET in 1 BOTTLE (59651-837-90) | Ezetimibe and Simvastatin | Aurobindo Pharma Limited | 2024-03-01 |
| 59651-0838-30 | 30 TABLET in 1 BOTTLE (59651-838-30) | Ezetimibe and Simvastatin | Aurobindo Pharma Limited | 2024-03-01 |
| 59651-0838-90 | 90 TABLET in 1 BOTTLE (59651-838-90) | Ezetimibe and Simvastatin | Aurobindo Pharma Limited | 2024-03-01 |
| 67877-0507-01 | 1000 TABLET in 1 BOTTLE (67877-507-01) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0507-30 | 30 TABLET in 1 BOTTLE (67877-507-30) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0507-38 | 10 BLISTER PACK in 1 CARTON (67877-507-38) / 10 TABLET in 1... | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0507-90 | 90 TABLET in 1 BOTTLE (67877-507-90) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0508-01 | 1000 TABLET in 1 BOTTLE (67877-508-01) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0508-30 | 30 TABLET in 1 BOTTLE (67877-508-30) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0508-38 | 10 BLISTER PACK in 1 CARTON (67877-508-38) / 10 TABLET in 1... | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0508-90 | 90 TABLET in 1 BOTTLE (67877-508-90) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0509-05 | 500 TABLET in 1 BOTTLE (67877-509-05) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0509-30 | 30 TABLET in 1 BOTTLE (67877-509-30) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0509-37 | 5 BLISTER PACK in 1 CARTON (67877-509-37) / 10 TABLET in 1... | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0509-90 | 90 TABLET in 1 BOTTLE (67877-509-90) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0510-05 | 500 TABLET in 1 BOTTLE (67877-510-05) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0510-30 | 30 TABLET in 1 BOTTLE (67877-510-30) | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
| 67877-0510-37 | 5 BLISTER PACK in 1 CARTON (67877-510-37) / 10 TABLET in 1... | Ezetimibe and Simvastatin | Ascend Laboratories, LLC | 2017-12-24 |
Observed labelers:
Ascend Laboratories, LLC (16) ·
Glenmark Pharmaceuticals Inc., USA (12) ·
Dr.Reddys Laboratories Inc (11) ·
Amneal Pharmaceuticals NY LLC (8) ·
Aurobindo Pharma Limited (8) ·
NORTHSTAR RX LLC (8)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.